Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of GDC-0919 for Adult Patients With Recurrent Advanced Solid Tumors

NCT02048709 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT02048709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02048709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of GDC-0919 for Adult Patients With Recurrent Advanced Solid Tumors
Lead sponsor
Genentech, Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
February 29, 2016
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor